• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Eris Lifesciences Limited — Updates, 20-03-2026: Press Release

    20-03-2026 | 04:08 pm

    Eris Lifesciences partnered with Natco Pharma to launch transformative drug Semaglutide in India, strengthening its diabetes & metabolic care portfolio. Targeting Type 2 diabetes & weight management, launch is expected soon.

    No comments yet. Be the first to comment!

    All announcements from Eris Lifesciences Limited